Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Flare Therapeutics

Flare Therapeutics to Participate in Jefferies Global Healthcare Conference
From Flare Therapeutics
Via GlobeNewswire
Flare Therapeutics to Present at Guggenheim Healthcare Talks 2023 Oncology Day
From Flare Therapeutics
Via Business Wire
Flare Therapeutics to Present at Piper Sandler 34th Annual Healthcare Conference
From Flare Therapeutics
Via Business Wire
Flare Therapeutics Presents Comprehensive Real-World Data in Advanced and Metastatic Urothelial Cancer in Support of Therapeutic Targeting of PPARG at 2022 EORTC-NCI-AACR Symposium
From Flare Therapeutics
Via Business Wire
Flare Therapeutics Presents Preclinical Data that Show Potential of Novel PPARG Inhibitors to Treat Urothelial Cancer at 2022 EORTC-NCI-AACR Symposium
From Flare Therapeutics
Via Business Wire
Flare Therapeutics Appoints Amit Rakhit, M.D. as President and Chief Executive Officer
From Flare Therapeutics
Via Business Wire
Flare Therapeutics to Present at the Bank of America Securities 2022 Healthcare Conference
From Flare Therapeutics
Via Business Wire
Flare Therapeutics Appoints Adrian Jubb as Chief Medical Officer
From Flare Therapeutics
Via Business Wire
Flare Therapeutics Appoints Daphne Karydas as COO and CFO, and Michaela Bowden, PhD, as SVP of Biology and Translation
From Flare Therapeutics
Via Business Wire
Flare Therapeutics Launches with $82 Million Series A Financing to Advance Precision Oncology Pipeline based on Novel Drug Discovery Approach for Transcription Factors
From Flare Therapeutics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.